These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

323 related items for PubMed ID: 21865039

  • 1. Synthesis of phenanthroindolizidine alkaloids and evaluation of their antitumor activities and toxicities.
    Ikeda T, Yaegashi T, Matsuzaki T, Yamazaki R, Hashimoto S, Sawada S.
    Bioorg Med Chem Lett; 2011 Oct 01; 21(19):5978-81. PubMed ID: 21865039
    [Abstract] [Full Text] [Related]

  • 2. Asymmetric synthesis of phenanthroindolizidine alkaloids with hydroxyl group at the C14 position and evaluation of their antitumor activities.
    Ikeda T, Yaegashi T, Matsuzaki T, Hashimoto S, Sawada S.
    Bioorg Med Chem Lett; 2011 Jan 01; 21(1):342-5. PubMed ID: 21126872
    [Abstract] [Full Text] [Related]

  • 3. Expedient synthesis and structure-activity relationships of phenanthroindolizidine and phenanthroquinolizidine alkaloids.
    Chuang TH, Lee SJ, Yang CW, Wu PL.
    Org Biomol Chem; 2006 Mar 07; 4(5):860-7. PubMed ID: 16493470
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Synthesis and SAR studies of phenanthroindolizidine and phenanthroquinolizidine alkaloids as potent anti-tumor agents.
    Wang Z, Wu M, Wang Y, Li Z, Wang L, Han G, Chen F, Liu Y, Wang K, Zhang A, Meng L, Wang Q.
    Eur J Med Chem; 2012 May 07; 51():250-8. PubMed ID: 22417638
    [Abstract] [Full Text] [Related]

  • 6. Antitumor agents 253. Design, synthesis, and antitumor evaluation of novel 9-substituted phenanthrene-based tylophorine derivatives as potential anticancer agents.
    Wei L, Shi Q, Bastow KF, Brossi A, Morris-Natschke SL, Nakagawa-Goto K, Wu TS, Pan SL, Teng CM, Lee KH.
    J Med Chem; 2007 Jul 26; 50(15):3674-80. PubMed ID: 17585747
    [Abstract] [Full Text] [Related]

  • 7. Design, synthesis, antiviral activity, and SARs of 13a-substituted phenanthroindolizidine alkaloid derivatives.
    Su B, Cai C, Deng M, Liang D, Wang L, Wang Q.
    Bioorg Med Chem Lett; 2014 Jul 01; 24(13):2881-4. PubMed ID: 24835986
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Antitumor agents 251: synthesis, cytotoxic evaluation, and structure-activity relationship studies of phenanthrene-based tylophorine derivatives (PBTs) as a new class of antitumor agents.
    Wei L, Brossi A, Kendall R, Bastow KF, Morris-Natschke SL, Shi Q, Lee KH.
    Bioorg Med Chem; 2006 Oct 01; 14(19):6560-9. PubMed ID: 16809043
    [Abstract] [Full Text] [Related]

  • 10. In vitro anticancer effects of two novel phenanthroindolizidine alkaloid compounds on human colon and liver cancer cells.
    Liu J, He Y, Zhang D, Cai Y, Zhang C, Zhang P, Zhu H, Xu N, Liang S.
    Mol Med Rep; 2017 Sep 01; 16(3):2595-2603. PubMed ID: 28677760
    [Abstract] [Full Text] [Related]

  • 11. Synthesis and evaluation of C-ring aromatized analogues of phenanthridone alkaloids.
    Lee S, Hwang S, Yu S, Jang W, Lee YM, Kim S.
    Arch Pharm Res; 2011 Jul 01; 34(7):1065-70. PubMed ID: 21811912
    [Abstract] [Full Text] [Related]

  • 12. Simplification of antitumoral phenanthroindolizidine alkaloids: short synthesis of cytotoxic indolizidinone and pyrrolidine analogs.
    Miguélez J, Boto A, Marín R, Díaz M.
    Eur J Med Chem; 2013 Aug 01; 66():540-54. PubMed ID: 23845713
    [Abstract] [Full Text] [Related]

  • 13. Antitumor effect of a novel phenanthroindolizidine alkaloid derivative through inhibition of protein synthesis.
    Ueno S, Yamazaki R, Ikeda T, Yaegashi T, Matsuzaki T.
    Anticancer Res; 2014 Jul 01; 34(7):3391-7. PubMed ID: 24982345
    [Abstract] [Full Text] [Related]

  • 14. Isolation and biological activities of phenanthroindolizidine and septicine alkaloids from the Formosan Tylophora ovata.
    Lee YZ, Huang CW, Yang CW, Hsu HY, Kang IJ, Chao YS, Chen IS, Chang HY, Lee SJ.
    Planta Med; 2011 Nov 01; 77(17):1932-8. PubMed ID: 21728149
    [Abstract] [Full Text] [Related]

  • 15. Anticancer effect and neurotoxicity of S-(+)-deoxytylophorinidine, a new phenanthroindolizidine alkaloid that interacts with nucleic acids.
    Liu ZJ, Lv HN, Li HY, Zhang Y, Zhang HJ, Su FQ, Si YK, Yu SS, Chen XG.
    J Asian Nat Prod Res; 2011 May 01; 13(5):400-8. PubMed ID: 21534037
    [Abstract] [Full Text] [Related]

  • 16. Antitumor agents 268. Design, synthesis, and mechanistic studies of new 9-substituted phenanthrene-based tylophorine analogues as potent cytotoxic agents.
    Yang X, Shi Q, Liu YN, Zhao G, Bastow KF, Lin JC, Yang SC, Yang PC, Lee KH.
    J Med Chem; 2009 Aug 27; 52(16):5262-8. PubMed ID: 19645447
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Design and synthesis of novel C14-hydroxyl substituted triptolide derivatives as potential selective antitumor agents.
    Li Z, Zhou ZL, Miao ZH, Lin LP, Feng HJ, Tong LJ, Ding J, Li YC.
    J Med Chem; 2009 Aug 27; 52(16):5115-23. PubMed ID: 19637874
    [Abstract] [Full Text] [Related]

  • 19. Recent Advances in Phenanthroindolizidine and Phenanthroquinolizidine Derivatives with Anticancer Activities.
    de Fatima Pereira M, Rochais C, Dallemagne P.
    Anticancer Agents Med Chem; 2015 Aug 27; 15(9):1080-91. PubMed ID: 25991426
    [Abstract] [Full Text] [Related]

  • 20. [Synthesis of 1-indole substituted beta-carboline alkaloid and its derivatives and evaluation of their preliminary antitumor activities].
    Dong XC, Wen R, Zheng JB.
    Yao Xue Xue Bao; 2004 Apr 27; 39(4):259-62. PubMed ID: 15303653
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.